Cite the Following Article
Computational methods in drug discovery
Sumudu P. Leelananda and Steffen Lindert
Beilstein J. Org. Chem. 2016, 12, 2694–2718.
https://doi.org/10.3762/bjoc.12.267
How to Cite
Leelananda, S. P.; Lindert, S. Beilstein J. Org. Chem. 2016, 12, 2694–2718. doi:10.3762/bjoc.12.267
Download Citation
Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window
below.
Citation data in RIS format can be imported by all major citation management software, including EndNote,
ProCite, RefWorks, and Zotero.
Presentation Graphic
Picture with graphical abstract, title and authors for social media postings and presentations. | ||
Format: PNG | Size: 503.0 KB | Download |
Citations to This Article
Up to 20 of the most recent references are displayed here.
Scholarly Works
- McMillan, J.; Bester, M. J.; Apostolides, Z. In silico docking and ADMET studies on clinical targets for type 2 diabetes correlated to in vitro inhibition of pancreatic alpha-amylase and alpha-glucosidase by rutin, caffeic acid, p-coumaric acid, and vanillin. In Silico Pharmacology 2025, 13. doi:10.1007/s40203-025-00324-6
- Paiva, V. A.; Pires, D. E. V.; Bressan, G. C.; Izidoro, S. C.; Silveira, S. A. BENDER DB: a database of protein binding sites across neglected disease proteomes. Cold Spring Harbor Laboratory 2025. doi:10.1101/2025.02.18.638856
- Mandujano-Lázaro, G.; Torres-Rojas, M. F.; Ramírez-Moreno, E.; Marchat, L. A. Virtual screening combined with molecular docking for the !identification of new anti-adipogenic compounds. Science progress 2025, 108, 368504251320313. doi:10.1177/00368504251320313
- Luo, J.; Zhu, Z.; Xu, Z.; Xiao, C.; Wei, J.; Shen, J. GS-DTA: integrating graph and sequence models for predicting drug-target binding affinity. BMC genomics 2025, 26, 105. doi:10.1186/s12864-025-11234-4
- Chen, S.; Hu, X.; Chen, F.; Liu, J.; Su, J.; Chen, R.; Wei, W.; Yuan, Z.; An, S.; Ye, L.; Liang, H.; Jiang, J. Forsythoside B activates Siglec-14 to inhibit HIV-1 replication via the JAK1/STAT1 pathway. International journal of biological macromolecules 2025, 303, 140632. doi:10.1016/j.ijbiomac.2025.140632
- Pereira, T. O.; Abbasi, M.; Arrais, J. P. ABIET: An explainable transformer for identifying functional groups in biological active molecules. Computers in biology and medicine 2025, 187, 109740. doi:10.1016/j.compbiomed.2025.109740
- Vijayalakshmi, G.; Perianayagi, L.; Kores, J. J.; Nayagam, B. R. D.; Jeyamalar, J. I. Unveiling the anticancer potential: Exploring 4-fluoro benzoic acid and piperazine through spectroscopic, X-ray diffraction, DFT and molecular docking analysis. Journal of Molecular Structure 2025, 1322, 140507. doi:10.1016/j.molstruc.2024.140507
- Sharma, S.; Darlami, J. QSAR Modeling and Its Application in Veterinary Drug Design. Bioinformatics in Veterinary Science; Springer Nature Singapore, 2025; pp 367–385. doi:10.1007/978-981-97-7395-4_15
- Mohamed, A.; Brooks, B. R.; Amin, M. The role of induced polarization in drug discovery applications. Cold Spring Harbor Laboratory 2025. doi:10.1101/2025.01.14.632933
- Dos Santos, G. P.; Coelho, A. C.; Reimão, J. Q. The latest progress in assay development in leishmaniasis drug discovery: a review of the available papers on PubMed from the past year. Expert opinion on drug discovery 2025, 20, 177–192. doi:10.1080/17460441.2025.2450787
- Alhawarri, M. B.; Al-Thiabat, M. G.; Dubey, A.; Tufail, A.; Banisalman, K.; Al Jabal, G. A.; Alkasasbeh, E.; Al-Trad, E. I.; Alrimawi, B. H. Targeting necroptosis in MCF-7 breast cancer cells: In Silico insights into 8,12-dimethoxysanguinarine from Eomecon Chionantha through molecular docking, dynamics, DFT, and MEP studies. PloS one 2025, 20, e0313094. doi:10.1371/journal.pone.0313094
- Elengoe, A. Programming, tools, and software. Systems Biology and In-Depth Applications for Unlocking Diseases; Elsevier, 2025; pp 149–155. doi:10.1016/b978-0-443-22326-6.00011-0
- Rai, A. K.; Pakyntein, C. L.; Nongrum, S.; Thabah, D.; Sunn, S. E.; Syiem, D. Potentilla fulgens Wall ex Sims. exerts anti-diabetic effects by inhibiting α-amylase and α-glucosidase: deeper insights through molecular docking. International Journal of Plant Based Pharmaceuticals 2025, 5, 1–15. doi:10.62313/ijpbp.2025.244
- Ouedraogo, M.; Ouedraogo, W. P.; Yameogo, H. W.; Traore, I. T.; Boly, R.; Ouedraogo, N.; Semde, R.; Ouedraogo, S. In Silico Inhibitory Potential of Isolated Molecules of Scoparia dulcis L. (Scrophulariaceae) on SARS-CoV-2 Main Protease Mpro. Pharmacology & Pharmacy 2025, 16, 31–51. doi:10.4236/pp.2025.162003
- Amjad, E.; Sokouti, B. Repurposing, effects, design, and discovery of drugs in systems biology. Systems Biology and In-Depth Applications for Unlocking Diseases; Elsevier, 2025; pp 305–318. doi:10.1016/b978-0-443-22326-6.00024-9
- Li, R.; Hasan, M. M.; Wang, D. In Silico Conotoxin Studies: Progress and Prospects. Molecules (Basel, Switzerland) 2024, 29, 6061. doi:10.3390/molecules29246061
- Shokova, E. A.; Kim, J. K.; Kovalev, V. V. Adamantane: On the 90th Anniversary of Its Appearance in Chemical Science. Russian Journal of Organic Chemistry 2024, 60, 1831–1891. doi:10.1134/s1070428024100014
- Barcelos, M. P.; de Paula da Silva, C. H. T. The Role of Artificial Intelligence in the Discovery of New Drugs. Engineering Materials; Springer Nature Switzerland, 2024; pp 353–370. doi:10.1007/978-3-031-75984-0_14
- Kathiresan, N.; Jayaprakash, P.; Langeswaran, K. Computational Approaches to Elucidate the Mechanism of Serine–Threonine Kinase (AKT1) Inhibition by Streptococcus pyogenes Exotoxin Superantigen‐Derived Peptides: Pioneering Cancer Therapy. Peptide Science 2024, 117. doi:10.1002/pep2.24388
- Mohammed, I.; Sagurthi, S. R. Current Approaches and Strategies Applied in First-in-class Drug Discovery. ChemMedChem 2024, e202400639. doi:10.1002/cmdc.202400639
Patents
- YUAN JIANN-SHIUN; CHAKRABARTI DEBOPAM; SALEM MILAD; ARSHADI ARASH KESHAVARZI. Artificial intelligence-based methods for early drug discovery and related training methods. US 12040094 B2, July 16, 2024.
- LIU JAY; YI MYUNG GI; ZUVELA PETAR. Method for screening of target-based drugs through numerical inversion of quantitative structure-(drug)performance relationships and molecular dynamics simulation. US 11705224 B2, July 18, 2023.